Liu et al. (2020) showed that circITCH, downregulated in MM, restores bortezomib (BTZ) sensitivity via the miR-615-3p/PRKCD axis, with circITCH overexpression enhancing BTZ response [49]. The gene discussed is PRKCD; the disease is Miyoshi myopathy.